Stephen D. Simpson, CFA, joined Northland Securities in December 2008 as a Senior Analyst covering medical technology companies. Mr. Simpson has extensive experience in the health care sector, having worked as a sell-side Equity Analyst at Piper Jaffray and more recently as a Consultant to the health care industry, focusing on the life sciences and metabolic/endocrine disease markets. He has a B.S.L.A. in Japanese from Georgetown University and holds a Series 7, Series 63, Series 86 and Series 87 license.
Blurred Lines Between Life Sciences & Diagnostics - Stephen D. Simpson - Northland Securities, Inc.
January 25, 2010
Diagnostics Industry Progress Investment Highlights - Stephen D. Simpson - Northland Securities
July 13, 2009